
FDA Approves Another Thyroid Cancer Indication for Nexavar (Sorafenib)
Publication year - 2013
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000441845.33666.b0
Subject(s) - sorafenib , thyroid cancer , medicine , cancer , oncology , hepatocellular carcinoma